» Authors » Huahui Yu

Huahui Yu

Explore the profile of Huahui Yu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 32
Citations 121
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Du Z, Wang Y, Li F, Sun X, Du Y, Li L, et al.
Research (Wash D C) . 2025 Feb; 8:0629. PMID: 40018730
Familial hypercholesterolemia (FH) is a lipoprotein disorder characterized by elevated plasma levels of low-density lipoprotein cholesterol (LDL-C) and an increased risk of premature atherosclerotic cardiovascular disease. Recent evidences have shown...
2.
Xing J, Du Z, Li F, Wang Y, Zhang Z, Gao X, et al.
Front Nutr . 2024 Dec; 11:1509577. PMID: 39737151
Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of mortality globally. Hypercholesterolemia accelerates atherosclerotic development and is an independent modifiable risk factor for ASCVD. Reducing cholesterol levels is effective...
3.
Han L, Hu C, Du Z, Yu H, Du Y, Li L, et al.
Front Cell Infect Microbiol . 2024 Oct; 14:1439744. PMID: 39431056
Background: High-fat diet (HFD)-induced hyperlipidemia, which is associated with gut microbiota disturbances, remains a major public health challenge. Glycerolipid metabolism is responsible for lipid synthesis and is thus involved in...
4.
Duan Y, Liu D, Yu H, Zhang S, Xia Y, Du Z, et al.
Cell Biosci . 2024 Oct; 14(1):126. PMID: 39354565
Background: Occludin, a crucial component of tight junctions, has emerged as a promising biomarker for the diagnosis of acute ischemic disease, highlighting its significant potential in clinical applications. In the...
5.
Wang Y, Li F, Gao X, Yu H, Du Z, Li L, et al.
J Endocrinol . 2024 Jun; 262(3). PMID: 38940622
Hypercholesterolemia is an independent risk factor for cardiovascular disease and lowering circulating levels of low-density lipoprotein cholesterol (LDL-C) can prevent and reduce cardiovascular events. MicroRNA-181d (miR-181d) can reduce the levels...
6.
Yu H, Jiao X, Lv Q, Li L, Du Y, Hu C, et al.
Aging Dis . 2024 Jun; PMID: 38913045
Abdominal aortic aneurysm (AAA) is a potentially life-threatening vascular disease primarily in the male elderly population, but there is a lack of approved medical therapies to prevent the progression and...
7.
Sun H, Du Z, Yu H, Hu C, Du Y, Qin Y
Sleep Med . 2024 Feb; 115:131-136. PMID: 38359592
Objective: Excessive daytime sleepiness (EDS) frequently accompanies obstructive sleep apnea (OSA) and may increase cardiovascular risks. The majority of coronary artery disease (CAD) patients receive understandard treatments, it is not...
8.
Li J, Su L, Jiang J, Wang Y, Ling Y, Qiu Y, et al.
Int J Mol Sci . 2024 Jan; 25(1). PMID: 38203469
Type I interferon (IFN-I)-induced signaling plays a critical role in host antiviral innate immune responses. Despite this, the mechanisms that regulate this signaling pathway have yet to be fully elucidated....
9.
Wang Z, Pan B, Su L, Yu H, Wu X, Yao Y, et al.
Cell Oncol (Dordr) . 2023 Dec; 47(2):513-532. PMID: 38055116
Purpose: High levels of heterogeneity and immunosuppression characterize the HCC immune microenvironment (TME). Unfortunately, the majority of hepatocellular carcinoma (HCC) patients do not benefit from immune checkpoint inhibitors (ICIs) therapy....
10.
Li L, Shao S, Wang Y, Du Z, Yu H, Li F, et al.
Am J Physiol Endocrinol Metab . 2023 Oct; 325(5):E638-E648. PMID: 37819197
AT-hook DNA-binding motif-containing protein 1 () is a causal gene of intellectual disability/developmental delay in humans. The biological role of AHDC1 is unclear. Recently, some clues from mutation carriers hinted...